Page 107 - CPG มะเร็งปากมดลูก
P. 107
แนวทางการปอ? งกันและรกั ษามะเรง็ ปากมดลูก 101
19. Zivanovic O, Leitao MM, Jr., Park KJ, Zhao H, Diaz JP, Konner J, et al. Small cell neuroendocrine carcinoma of the
cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Gynecol Oncol. 2009;112:590-3.
20. Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ. Prognostic factors in neuroendocrine small cell cervical
carcinoma: a multivariate analysis. Cancer. 2003;97:568-74.
21. Berm?dez A, Vighi S, Garc?a A, Sardi J. Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge.
Gynecol Oncol. 2001;82:32-9.
22. Chang TC, Hsueh S, Lai CH, Tseng CJ, Lee KF, Huang KG, et al. Phase II trial of neoadjuvant chemotherapy in early-
stage small cell cervical cancer. Anticancer Drugs. 1999;10:641-6.
23. Frumovitz M, Munsell MF, Burzawa JK, Byers LA, Ramalingam P, Brown J, et al. Combination therapy with
topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine
carcinoma of the cervix. Gynecol Oncol. 2017;144:46-50.
24. Roth BJ, Johnson DH, Einhorn LH, Schacter LP, Cherng NC, Cohen HJ, et al. Randomized study of
cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two
regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin
Oncol. 1992;10:282-91.
25. Liu R, He X, Li Z. Positive clinical outcomes following therapy with programmed cell death protein 1/programmed
cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix. Front Pharmacol. 2022;13:1029598.
26. Lara PN, Jr., Natale R, Crowley J, Lenz HJ, Redman MW, Carleton JE, et al. Phase III trial of irinotecan/cisplatin
compared with etoposide/ cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic
results from SWOG S0124. J Clin Oncol. 2009;27:2530-5.
27. Baykal C, Al A, Tulunay G, Bulbul D, G?ler G, Ozer S, et al. High-grade neuroendocrine carcinoma of the cervix. A
case report. Gynecol Obstet Invest. 2005;59:207-11.
28. Intaraphet S, Kasatpibal N, Siriaunkgul S, Sogaard M, Patumanond J, Khunamornpong S, et al. Prognostic impact of
histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine
carcinoma. Asian Pac J Cancer Prev. 2013;14:5355-60.
29. Salani R, Khanna N, Frimer M, Bristow RE, Chen LM. An update on post-treatment surveillance and diagnosis of
recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations.
Gynecol Oncol. 2017;146:3-10.
